Two high blood pressure, depression drugs to be withdrawn from market
Taipei, Aug. 19 (CNA) Two drugs used to treat high blood pressure and depression will be withdrawn from the Taiwan market in early 2025 and late 2024, according to the Taiwan Food and Drug Administration (TFDA), which noted that locally produced generic drugs will fill the gap.